Symposium on muscle
Muscular dystrophy: Review and recent observations

https://doi.org/10.1016/0002-9343(63)90135-9Get rights and content

First page preview

First page preview
Click to open first page preview

References (84)

  • P.E. Becker

    Neue Ergebnisse der Genetik der Muskeldystrophien

    Acta genet. med. et. gemel

    (1957)
  • P.E. Becker

    Two new families of benign sex-linked recessive muscular dystrophy

    Rev. canad. de Biol.

    (1962)
  • R.D. Adams et al.

    Diseases of Muscle: A Study in Pathology

  • C.M. Pearson et al.

    Hereditary nonprogressive muscular dystrophy inducing arthrogryposis syndrome

    Brain

    (1963)
  • L.G. Kiloh et al.

    Progressive dystrophy of external ocular muscles (ocular myopathy)

    Brain

    (1951)
  • L. Welander

    Myopathia distalis tarda hereditaria

    Acta med. scandinav.

    (1951)
  • C.M. Pearson

    Pathology of human muscular dystrophy

  • G.W. Pearce et al.

    Progressive muscular dystrophy: the histopathological changes in skeletal muscle obtained by biopsy

    J. Path. & Bact.

    (1962)
  • C.M. Pearson

    Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. I. Serum glutamic oxalacetic transaminase

    New England J. Med

    (1957)
  • C.S. Chung et al.

    Serum enzymes and genetic carriers in muscular dystrophy

    Am. J. Human Genet.

    (1960)
  • C.M. Pearson

    Histopathological features of muscle in the preclinical stages of muscular dystrophy

    Brain

    (1962)
  • C.M. Pearson et al.

    Studies of enzymes in serum in muscular dystrophy. II. Diagnostic and prognostic significance in relatives of dystrophic persons

    Pediatrics

    (1961)
  • J.C. Dreyfus et al.

    Biochemistry of Hereditary Myopathies

  • G. Schapira et al.

    Biochemistry of progressive muscular dystrophy

  • P.J. Vignos et al.

    A biochemical study of certain skeletal muscle constituents in human progressive muscular dystrophy

    J. Clin. Invest.

    (1959)
  • B. Horvath et al.

    Muscular dystrophy: quantitative studies on the composition of dystrophic muscle

    Res. Publ., A. Nerv. & Ment. Dis.

    (1960)
  • P.A. Levéne et al.

    Factors regulating the creatinine output in man

    Am. J. Physiol.

    (1909)
  • A.T. Milhorat et al.

    Studies of diseases in muscle. I. Metabolism of creatine and creatinine in progressive muscular dystrophy

    Arch. Neurol. & Psychiat.

    (1937)
  • J.C. Dreyfus et al.

    Serum enzymes in the pathophysiology of muscle

    Ann. New York Acad. Sc.

    (1958)
  • H. Berger

    Aminoaciduria in progressive muscular dystrophy

    Rev. canad. de Biol.

    (1962)
  • G. Schapira et al.

    L'élévation du taux de Paldolase sérique, test biochemique des myopathies

    Semaine hôp. Paris

    (1953)
  • W.H.S. Thomson et al.

    Serum enzyme activity in muscular dystrophy

    Brit. M. J.

    (1960)
  • S. Ebashi et al.

    High creatine phosphokinase activity of sera of progressive muscular dystrophy

    J. Biochem.(Tokyo)

    (1959)
  • J.C. Dreyfus et al.

    Étude de la créatine-kinase sérique chez les myopathes et leurs familles

    Rev. Franc. Étud. clin. biol.

    (1960)
  • S. Okinaka

    Serum creatine phosphokinase activity in progressive muscular dystrophy and neuromuscular diseases

    Arch. Neurol.

    (1961)
  • G.M. Pearson

    Biochemical and histological features of early muscular dystrophy

    Rev. canad. de Biol.

    (1962)
  • S.R. Chowdhury et al.

    Serum enzyme studies in muscular dystrophy. III. Serum malic dehydrogenase, 5-nucleotidase and adenosinetri-phosphatase

  • Fowler, W. M. and Pearson, C. M. To be...
  • F. Schapira et al.

    Étude de l'aldolase et de la créatine kinase du serum chez les mères de myopathies

    Rev. Franc. Étud. clin. biol.

    (1960)
  • U. Aebi et al.

    Progressive muscular dystrophy. II. Biochemical identification of the carrier state in recessive sex-linked juvenile (Duchenne) type by serum creatine-phosphokinase determinations

    Enzymol. biol. clin.

    (1961)
  • R. Richterich et al.

    Progressive muscular dystrophy. V. The identification of the carrier state in the Duchenne type by serum creatine kinase determination

    Am. J. Human Genet.

    (1963)
  • B.P. Hughes

    Serum enzymes in carriers of muscular dystrophy

    Brit. M. J.

    (1962)
  • Cited by (34)

    • Combining passive leg-lifting with transmural myocardial strain profile for enhanced predictive capability for subclinical left ventricular dysfunction in Duchenne muscular dystrophy

      2015, Journal of Cardiology
      Citation Excerpt :

      Since subclinical LV myocardial dysfunction may develop and progress early in life, the early detection of this abnormality in DMD patients when their LVEF remains preserved is important because medical treatment can be administered earlier, and is therefore vital for prevention of the development of myocardial fibrosis [19,20]. Fibrotic changes, however, do not always occur homogeneously in the heart and cardiac fibrosis in DMD patients begins in the outer half of the myocardium, especially in the LV posterior wall [21,22]. Moreover, early detection of subclinical LV dysfunction in DMD patients with preserved LVEF can be challenging [23].

    • Utility of transmural myocardial strain profile for prediction of early left ventricular dysfunction in patients with Duchenne muscular dystrophy

      2013, American Journal of Cardiology
      Citation Excerpt :

      The cardiac involvement caused by DMD progresses toward cardiomyopathy with dilation of the chambers and suppression of LV function and is responsible for death in approximately 40% of patients aged 10 to 30 years.11–15 Histologic changes in the heart of patients with DMD have been identified as fibrosis, degeneration, and fatty infiltration.16,17 Fibrotic changes, however, do not always occur homogeneously in the heart and cardiac fibrosis in patients DMD begins in the outer ½ of the myocardium, especially in the LV posterior wall.16,17

    • The heart in neuromuscular disease

      1986, Current Problems in Cardiology
    View all citing articles on Scopus

    Parts of this study were supported by grants from the Muscular Dystrophy Associations of America.

    1

    From the Department of Medicine, U.C.L.A. Center for the Health Sciences and Wadsworth Hospital, Veterans Administration Center, Los Angeles, California.

    View full text